Effect of Acute Endurance Exercise on the Production of FGF21 and Follistatin in Patients With Hepatocellular Carcinoma
NCT07189624 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2025-12-31
Summary
The main purpose of the study is to characterize the production of hepatokines (FGF21 and Follistatin) in response to a submaximal exercise on an ergocycle, in patients with hepatocellular carcinoma. The effect of exercise on hepatokines and metabolites production in liver cancer patients is not known. Studying this production could help to provide relevant recommendations for training programming in these patients.
Conditions
- Cirrhosis With Hepatocellular Carcinoma
Interventions
- OTHER
-
Exercise
30-minutes exercise on a bicycle with heart rate monitor and gas exchange analyzer.
Sponsors & Collaborators
-
University Hospital, Clermont-Ferrand
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-31
- Primary Completion
- 2028-04-30
- Completion
- 2029-04-30
Countries
- France
Study Locations
More Related Trials
-
Relationship Between FGF19 Overexpression and Disease Prognosis
NCT06938451 ·Status: NOT_YET_RECRUITING
-
Fatty Acids, Genes and Microbiota in Fatty Liver
NCT02148471 ·Status: COMPLETED
-
Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
NCT06681818 ·Status: RECRUITING ·Phase: NA
-
The Clinicopathological and Prognostic Factors of Hepatocellular Carcinoma; 10 Years' Tertiary Center Experience in Egypt
NCT05047146 ·Status: COMPLETED
-
Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC)
NCT00866957 ·Status: COMPLETED
-
Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.
NCT01729221 ·Status: UNKNOWN
-
Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD
NCT04774302 ·Status: COMPLETED
-
Sleep Apnoea Syndrome and Hepatocellular Carcinoma
NCT04190498 ·Status: WITHDRAWN
-
Transient Elastography in Hepatectomy for Hepatocellular Carcinoma
NCT01441453 ·Status: UNKNOWN ·Phase: NA
-
Is There an Association Between Quadriceps Strength and Different Markers of Fragility in Patients With Cirrhosis?
NCT06133127 ·Status: COMPLETED ·Phase: NA
-
Analysis of Body Composition in Patients With Hepatocellular Carcinoma in Radioablation
NCT01744639 ·Status: WITHDRAWN ·Phase: NA
-
Discrepancies in Management of Hepatocellualr Carcinoma Between Practice and Recommendations
NCT04189809 ·Status: UNKNOWN
-
Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment
NCT01492127 ·Status: UNKNOWN ·Phase: NA
-
Screening for Chronic Liver Diseases in General Population
NCT06366425 ·Status: RECRUITING ·Phase: NA
-
The Effect of Mobile Health-based Exercise on Hepatocellular Carcinoma Patients With Insulin Resistance
NCT04649671 ·Status: TERMINATED ·Phase: NA
-
Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis
NCT03142698 ·Status: UNKNOWN ·Phase: NA
-
Characterization of the Intrahepatic Inflammatory Microenvironment in Patients With Non-alcoholic Steatohepatitis
NCT06152250 ·Status: RECRUITING ·Phase: NA
-
Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis
NCT00190385 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Indocyanine Green as a Near-Infrared Fluorescent Contrast Agent for Image-guided Liver Surgery
NCT01738217 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Liver Regeneration After Liver Resection
NCT01220986 ·Status: UNKNOWN
-
Non Alcoholic Steatohepatitis in Relation to Visceral and Subcutaneous Fat
NCT04240145 ·Status: UNKNOWN
-
Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic Targets
NCT03979417 ·Status: COMPLETED
-
Sarcopenia and Systemic Therapy in HCC
NCT06805552 ·Status: RECRUITING
-
Effects of Hepatic Fibrosis on Hepatic Steatosis Using the Ultrasound Attenuation Imaging in Chronic Hepatitis B
NCT05871749 ·Status: COMPLETED
-
NMR-based Metabolic Profiling Identifies High Risk of MAFLD Patients With Advanced Fibrosis
NCT05734599 ·Status: UNKNOWN